Laser Photonics Corp is offering up to 10,500,000 common shares alongside Series B-1 and Series B-2 warrants, each covering up to 10,500,000 common shares. The package matters to investors because Warrant exercise can create further dilution, while the prospectus warns purchasers of immediate and substantial dilution.
Key Highlights
- Series B-1 and Series B-2 warrants together cover 21,000,000 underlying common shares.
- The offering is being conducted on a best-efforts basis.
- Placement agent warrants cover up to 735,000 common shares.
Laser Photonics Corp (NASDAQ: LASE) is offering up to 10,500,000 common shares with accompanying Series B-1 and Series B-2 warrants. Each warrant series covers the purchase of up to 10,500,000 common shares, creating 21,000,000 common shares underlying the two warrant series. The securities are being offered on a best-efforts basis.
10,500,000 Shares Offered
The common stock carries a Par Value of $0.001 per share. The offering consists of the shares and two warrant classes issued alongside them. Series B-1 warrants allow purchases of up to 10,500,000 common shares. Series B-2 warrants cover the same number of shares. Together, the common warrants relate to 21,000,000 shares of common stock.
735,000 Placement Agent Warrants
The prospectus separately identifies 735,000 shares of common stock underlying those warrants. The placement agent warrants are distinct from the Series B-1 and Series B-2 warrants. The latter two classes together cover 21,000,000 underlying common shares, while the placement agent warrants cover up to 735,000 shares.
Existing Warrant Overhang
The share count used for the post-offering calculation is based on 50,170,338 common shares outstanding. That calculation excludes 118,032 remaining unexercised shares tied to underwriters’ warrants. It also excludes 1,050,000 warrants that can purchase 4,557,000 common shares. Other excluded instruments include Series A warrants and Series B warrants, each covering up to 1,098,902 shares. The excluded securities also include Series A-1 and Series A-2 warrants, each covering up to 7,142,858 shares. Series A-3 and Series A-4 warrants each cover up to 1,373,630 shares. Series A-5 warrants cover up to 4,742,860 shares, while Series A-6 warrants cover up to 6,687,310 shares. Series A-7 warrants cover up to 800,000 shares, and unregistered Series A-8 warrants cover up to 4,257,144 shares. Purchasers are warned that exercising outstanding Options or warrants would create further dilution. The prospectus also states that additional Equity or convertible Debt Financing could result in further dilution.
Dilution For New Investors
The company also states that it may raise additional Capital through equity or convertible debt securities.




Please wait processing your request...